Closed
Source change captured:
Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study
AI-guided trauma transfusion research program
Offered by
Get notified when Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study reopens
Location
Canada
Overview
Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study supports multidisciplinary research teams with 255,000 $ in 2026-2027 and 145,000 $ in 2027-2028 to validate AI models for personalized trauma transfusion care. Eligible work includes prospective and retrospective validation, real-time point-of-care data integration, and model refinement.
Receipt of requests is now closed
Get notified about updates to this grant.
At a glance
Funding available
Financing goals
- Increase performance through digital transformation
- Develop a new product or service
- Conduct research and development activities
Eligible Funding
- Varies by project
Funds Providers
Eligible candidates
Eligible Industries
- All industries
Location
- Canada
Legal structures
- Non-profit
- Public or Parapublic institution
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Non-profit candidates
Sector of operation
- All industries
Target groups
- All the groups
Revenue structures
- All structures
Scope
- All dimensions
Next Steps
1
Determine your project
Availability timeline
2026
Periods: 2
Activities funded
- Validate and refine trauma transfusion decision-support models using prospective and retrospective data.
- Integrate real-time point-of-care data from ROTEM, FloPatch and/or point-of-care INR systems.
- Develop a real-time transfusion decision-making prototype.
- Evaluate model ability to predict massive hemorrhage protocol activation, transfusion needs, and patient outcomes within 24 hours of injury.
Documents Needed
- Research funding application form
Sources and recorded changes
- Source change captured
- Change recorded
- Record updated
A captured source change or record update does not confirm eligibility. Check the funder’s current rules before applying.
Application deadline moved to September 28, 2026
The application deadline for this Phase II study moved from August 28, 2026 to September 28, 2026.
The application deadline for Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study moved from August 28, 2026 to September 28, 2026. No other funding, scope, or eligibility details were changed in the reviewed source.
Eligibility
Who is eligible?
- Multidisciplinary research teams.
- Teams affiliated with at least one Level 1 trauma center.
- Teams with expertise in trauma resuscitation, AI and machine learning, and clinical trial design.
- Teams with access to high-performance computing resources and large military and civilian trauma datasets.
How to apply
- Download and submit the research funding application form.
Processing and Agreement
- Collaborate with the RDDC-CRT research team.
- Attend project meetings to provide updates and preliminary results.
- Submit regular progress reports in a timely manner, as needed.
- Collect real-time point-of-service datasets and share anonymized data with RDDC-CRT.
- Obtain research ethics board approval from an accredited Canadian institution before funds are released.
Contacts
Frequently Asked Questions about the Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study Program
What is the Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study?
Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study supports multidisciplinary research teams with 255,000 $ in 2026-2027 and 145,000 $ in 2027-2028 to validate AI models for personalized trauma transfusion care. Eligible work includes prospective and retrospective validation, real-time point-of-care data integration, and model refinement.
Who is eligible for the Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study program?
To be eligible for the Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study program, you must:
Must be affiliated with at least one Level 1 trauma center.
Must include a multidisciplinary team led by a principal physician with trauma care expertise.
Must have a clearly defined and feasible plan for model validation, refinement, and clinical implementation.
Who can I contact for more information about the Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study?
You can contact Veterans Affairs Canada (VAC) by email at research-recherche@veterans.gc.ca.
Where is the Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study available?
The Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study program is available across Canada.
Is the Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study a grant, loan, or tax credit?
Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study is a Grant and Funding
Who are the financial supporters of the Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study?
Clinical Evaluation and Assessment of AI-enabled Transfusion Decision Support Systems for Personalized Trauma Care: Phase II Study is funded by Veterans Affairs Canada (VAC)